Jeremy W. Vandiver, Pharm.D., BCPS

Jeremy W. Vandiver, Pharm.D., BCPS

University of Wyoming

H-index: 8

North America-United States

About Jeremy W. Vandiver, Pharm.D., BCPS

Jeremy W. Vandiver, Pharm.D., BCPS, With an exceptional h-index of 8 and a recent h-index of 8 (since 2020), a distinguished researcher at University of Wyoming, specializes in the field of Internal Medicine, Family Medicine, Anticoagulation.

His recent articles reflect a diverse array of research interests and contributions to the field:

Strengthening Student Success: Investing in the Future of Pharmacy at University of Wyoming Through Wellness

Fanconi syndrome and euglycemic diabetic ketoacidosis secondary to canagliflozin use in a type 2 diabetic

Oral antivirals for high-risk COVID-19 patients

Perceptions of programs that orient non-practice faculty to the pharmacy profession: A pilot study

It's time to rethink your approach to C diff infection.

Comparison of continuation of low-molecular-weight heparin versus switching to unfractionated heparin in the peripartum

Clostridium perfringens as an unusual cause of a prosthetic joint infection following total knee arthroplasty

Jeremy W. Vandiver, Pharm.D., BCPS Information

University

Position

School of Pharmacy

Citations(all)

533

Citations(since 2020)

374

Cited By

284

hIndex(all)

8

hIndex(since 2020)

8

i10Index(all)

8

i10Index(since 2020)

8

Email

University Profile Page

University of Wyoming

Google Scholar

View Google Scholar Profile

Jeremy W. Vandiver, Pharm.D., BCPS Skills & Research Interests

Internal Medicine

Family Medicine

Anticoagulation

Top articles of Jeremy W. Vandiver, Pharm.D., BCPS

Title

Journal

Author(s)

Publication Date

Strengthening Student Success: Investing in the Future of Pharmacy at University of Wyoming Through Wellness

American Journal of Pharmaceutical Education

Elliott M Sogol

Jaime Hornecker

Michelle L Balkely

Michelle L Hilaire

Tracy D Mahvan

...

2023/8/1

Fanconi syndrome and euglycemic diabetic ketoacidosis secondary to canagliflozin use in a type 2 diabetic

Journal of Clinical and Translational Endocrinology: Case Reports

Nicholas Arlas

Jeremy W Vandiver

2022/3/1

Oral antivirals for high-risk COVID-19 patients

US Pharmacist

Lauren Biehle

JW Vandiver

2022

Perceptions of programs that orient non-practice faculty to the pharmacy profession: A pilot study

Currents in Pharmacy Teaching and Learning

Jennifer T Lamberts

Jeremy W Vandiver

Kimberly K Daugherty

Margarita V DiVall

Lisa Lebovitz

...

2021/7/1

It's time to rethink your approach to C diff infection.

The Journal of Family Practice

Kelsea Zukauckas

Jeremy Vandiver

Lauren Biehle

2020/7/1

Comparison of continuation of low-molecular-weight heparin versus switching to unfractionated heparin in the peripartum

American Journal of Perinatology

Christopher A Enakpene

Kristina N Pontarelli

Micaela Della Torre

2020/2

Clostridium perfringens as an unusual cause of a prosthetic joint infection following total knee arthroplasty

IDCases

Gina Stroud

Jeremy W Vandiver

2020/1/1

See List of Professors in Jeremy W. Vandiver, Pharm.D., BCPS University(University of Wyoming)